Effective Date of Requirement for Premarket Approval for Cardiovascular Permanent Pacemaker Electrode; Correction, 53851 [2011-22107]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 168 / Tuesday, August 30, 2011 / Proposed Rules
internationally? What impacts, either
positive or negative, would result from
an alignment of NRC regulatory
requirements and guidance with
international standards?
8. Should licensees be required to
monitor and report LDE for foreign
workers and report the values upon
request? Are there other impacts (e.g.,
operational, administrative, costs, etc.)
that should be anticipated if the U.S.
regulatory structure were to be different
from that being used in other countries?
9. Are there any other NRC
regulations and regulatory guidance that
might need to be reviewed and revised
as a result of ICRP recommendations in
reducing the allowable dose to the lens
of the eye?
10. How are licensees monitoring to
demonstrate compliance with the
existing dose limits for the lens of the
eye?
Dated at Rockville, Maryland, this 19th day
of August 2011.
For the Nuclear Regulatory Commission.
Josephine M. Piccone,
Director, Division of Intergovernmental
Liaison and Rulemaking, Office of Federal
and State Materials and Environmental
Management Programs.
[FR Doc. 2011–21900 Filed 8–29–11; 8:45 am]
Radiological Health, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 4622, Silver Spring,
MD 20993–0002, 301–796–6216.
SUPPLEMENTARY INFORMATION: In FR Doc.
2011–19959, appearing on page 48058,
in the Federal Register of Monday,
August 8, 2011, the following correction
is made:
1. On page 48062, in the first column,
under ‘‘XIII. References,’’ the first
reference is corrected to read ‘‘1. Geiger,
D.R., ‘‘FY 2003 and 2004 Unit Costs for
the Process of Medical Device Review,’’
September 2005, https://www.fda.gov/
downloads/MedicalDevices/Device
RegulationandGuidance/Overview/
MedicalDeviceUserFeeand
ModernizationActMDUFMA/ucm
109216.’’
Dated: August 24, 2011.
Nancy K. Stade,
Deputy Director for Policy, Center for Devices
and Radiological Health.
[FR Doc. 2011–22107 Filed 8–29–11; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
24 CFR Part 203
BILLING CODE 7590–01–P
[Docket No. FR–5461–P–01]
RIN 2502–AJ01
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Federal Housing Administration (FHA):
Suspension of Section 238(c) SingleFamily Mortgage Insurance in Military
Impacted Areas
Food and Drug Administration
21 CFR Part 870
Effective Date of Requirement for
Premarket Approval for Cardiovascular
Permanent Pacemaker Electrode;
Correction
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Proposed rule; correction.
The Food and Drug
Administration (FDA) is correcting a
proposed rule that appeared in the
Federal Register of August 8, 2011
(76 FR 48058). The document proposed
to require the filing of a premarket
approval application or a notice of
completion of a product development
protocol for the class III preamendments
device: Cardiovascular permanent
pacemaker electrode. The document
was published with an incorrect
Internet address for the first reference in
the References section. This document
corrects that error.
FOR FURTHER INFORMATION CONTACT:
Elias Mallis, Center for Devices and
srobinson on DSK4SPTVN1PROD with PROPOSALS
SUMMARY:
VerDate Mar<15>2010
18:48 Aug 29, 2011
Jkt 223001
Office of the Assistant
Secretary of Housing—Federal Housing
Commissioner, HUD.
ACTION: Proposed rule.
AGENCY:
[Docket No. FDA–2011–N–0505]
This proposed rule would
suspend FHA’s mortgage insurance
program for military impacted areas
under section 238(c) of the National
Housing Act (Act). This single-family
mortgage insurance program,
established by regulation in 1977, has
been significantly underutilized for the
past several years. Additionally, these
mortgage loans are insured under
comparable terms and conditions as
loans insured under HUD’s primary
single-family mortgage insurance
program under section 203(b) of the
National Housing Act. Accordingly,
those borrowers who would be served
under section 238(c) of the Act are
served equally well under the section
203(b) mortgage insurance program. The
suspension of this mortgage insurance
program is consistent with the
President’s budget request for Fiscal
Year 2012.
SUMMARY:
PO 00000
Frm 00010
Fmt 4702
Sfmt 4702
DATES:
53851
Comment Due Date: October 31,
2011.
Interested persons are
invited to submit comments regarding
this proposed rule to the Regulations
Division, Office of General Counsel,
Department of Housing and Urban
Development, 451 7th Street, SW.,
Room 10276, Washington, DC 20410–
0500. Communications must refer to the
above docket number and title. There
are two methods for submitting public
comments.
1. Submission of Comments by Mail.
Comments may be submitted by mail to
the Regulations Division, Office of
General Counsel, Department of
Housing and Urban Development, 451
7th Street, SW., Room 10276,
Washington, DC 20410–0001.
2. Electronic Submission of
Comments. Interested persons may
submit comments electronically through
the Federal eRulemaking Portal at
https://www.regulations.gov. HUD
strongly encourages commenters to
submit comments electronically.
Electronic submission of comments
allows the commenter maximum time to
prepare and submit a comment, ensures
timely receipt by HUD, and enables
HUD to make them immediately
available to the public. Comments
submitted electronically through the
https://www.regulations.gov Web site can
be viewed by other commenters and
interested members of the public.
Commenters should follow the
instructions provided on that site to
submit comments electronically.
ADDRESSES:
Note: To receive consideration as public
comments, comments must be submitted
through one of the two methods specified
above. Again, all submissions must refer to
the docket number and title of the rule. No
Facsimile Comments. Facsimile (FAX)
comments are not acceptable.
Public Inspection of Public
Comments. All properly submitted
comments and communications
submitted to HUD will be available for
public inspection and copying between
8 a.m. and 5 p.m. weekdays at the above
address. Due to security measures at the
HUD Headquarters building, an advance
appointment to review the public
comments must be scheduled by calling
the Regulations Division at 202–708–
3055 (this is not a toll-free number).
Individuals with speech or hearing
impairments may access this number
via TTY by calling the toll-free Federal
Relay Service at 800–877–8339. Copies
of all comments submitted are available
for inspection and downloading at
https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Karin Hill, Director, Office of Single
E:\FR\FM\30AUP1.SGM
30AUP1
]]>Agencies
[Federal Register Volume 76, Number 168 (Tuesday, August 30, 2011)]
[Proposed Rules]
[Page 53851]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-22107]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 870
[Docket No. FDA-2011-N-0505]
Effective Date of Requirement for Premarket Approval for
Cardiovascular Permanent Pacemaker Electrode; Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Proposed rule; correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is correcting a
proposed rule that appeared in the Federal Register of August 8, 2011
(76 FR 48058). The document proposed to require the filing of a
premarket approval application or a notice of completion of a product
development protocol for the class III preamendments device:
Cardiovascular permanent pacemaker electrode. The document was
published with an incorrect Internet address for the first reference in
the References section. This document corrects that error.
FOR FURTHER INFORMATION CONTACT: Elias Mallis, Center for Devices and
Radiological Health, Food and Drug Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 4622, Silver Spring, MD 20993-0002, 301-796-6216.
SUPPLEMENTARY INFORMATION: In FR Doc. 2011-19959, appearing on page
48058, in the Federal Register of Monday, August 8, 2011, the following
correction is made:
1. On page 48062, in the first column, under ``XIII. References,''
the first reference is corrected to read ``1. Geiger, D.R., ``FY 2003
and 2004 Unit Costs for the Process of Medical Device Review,''
September 2005, https://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/Overview/MedicalDeviceUserFeeandModernizationActMDUFMA/ucm109216.''
Dated: August 24, 2011.
Nancy K. Stade,
Deputy Director for Policy, Center for Devices and Radiological Health.
[FR Doc. 2011-22107 Filed 8-29-11; 8:45 am]
BILLING CODE 4160-01-P
